Biology of Kaposi's sarcoma

European Journal of Cancer

Volumn 37, Issue 10, 2001, Pages 1251-1269

  Ensoli, B ^a   Sgadari, C ^a   Barillari, G ^a   Sirianni, M C ^b   Sturzl M ^c   Monini, P ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

AIDS; Angiogenesis; Angiogenic factors; bcl 2; HHV8; HIV 1 Tat; Immune evasion; Inflammatory cytokines; KS; Spindle cells

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CD8 ANTIGEN; G PROTEIN COUPLED RECEPTOR; GAMMA INTERFERON; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LYMPHOTOXIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; PLATELET DERIVED GROWTH FACTOR B; RANTES; SCATTER FACTOR; TRANSACTIVATOR PROTEIN; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANGIOGENESIS; CANCER RISK; CELL ACTIVATION; CELL ADHESION; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE EXACERBATION; ENDOTHELIUM CELL; EXTRAVASATION; GENE EXPRESSION; HERPES; HISTOPATHOLOGY; HUMAN; HUMAN HERPESVIRUS 8; IMMUNOREACTIVITY; IMMUNOREGULATION; KAPOSI SARCOMA; ONCOGENE; PRIORITY JOURNAL; REVIEW; SPINDLE CELL; T LYMPHOCYTE;

EID: 0034969034     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(01)00121-6     Document Type: Article

References (136)

1. Kaposi's sarcoma in Italy before and after the AIDS epidemic
2. Kaposi's sarcoma in organ transplant recipients: Report of 20 cases
3. The appearance of Kaposi's sarcoma during corticosteroid therapy
4. Kaposi's sarcoma in mainland Tanzania: A report of 117 cases
5. Kaposi's sarcoma in Uganda: Geographic and ethnic distribution
6. Disseminated Kaposi's sarcoma syndrome in young homosexual men
7. Prevalence of Kaposi's sarcoma among patients with AIDS
8. Kaposi's sarcoma among persons with AIDS: A sexually transmitted infection?
9. The natural history of Kaposi's sarcoma in the acquired immunodeficiency syndrome
10. Kaposi's sarcoma: A reversible hyperplasia
11. Spontaneously healing Kaposi's sarcoma in AIDS
12. Clinical and biological impact of antiretroviral therapy with protease inhibitors on HIV-related Kaposi's sarcoma
13. Regression of AIDS-related Kaposi's sarcoma associated with clearance of human herpesvirus-8 from peripheral blood mononuclear cells following initiation of antiretroviral therapy
14. Cytogenetic study of Kaposi associated with acquired immunodeficiency syndrome
15. Evidence for multiclonality in multicentric Kaposi's sarcoma
16. Flow cytometric DNA content in Kaposi's sarcoma by histologic stage: Comparison with angiosarcoma
17. Microsatellite instability in primary neoplasms from HIV+ patients
18. AIDS-related Kaposi's sarcoma is a monoclonal neoplasm
19. Monoclonal origin of multicentric Kaposi's sarcoma lesions
20. γ-Interferon produced by CD8+-T cells infiltrating Kaposi's sarcoma induces spindle cells with angiogenic phenotype and synergy with HIV-1 Tat protein: An immune response to HHV-8 infection?
21. γ-Interferon production in peripheral blood mononuclear cells (PBMC) and tumour infiltrating lymphocytes from Kaposi's sarcoma patients: Correlation with the presence of human herpesvirus-8 in PBMC and lesional macrophages
22. Aortic endothelium in HIV-1 infection: Chronic injury, activation, and increased leukocyte adherence
23. Cytokines from activated T cells induce normal endothelial cells to acquire the phenotypic and functional features of AIDS-Kaposi's sarcoma spindle cells
24. IFN-γ induces endothelial cells to proliferate and to invade the extracellular matrix in response to the HIV-1 Tat protein: Implications for AIDS-Kaposi's sarcoma pathogenesis
25. Inflammatory cytokines synergize with the HIV-1 Tat protein to promote angiogenesis and Kaposi's sarcoma via induction of bFGF and αvβ3 integrin that are required for Tat activity
26. The Tat protein of human immunodeficiency virus type-1 promotes vascular cell growth and locomotion by engaging the α5β3 integrins and by mobilizing sequestered basic fibroblast growth factor
27. Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma are induced by inflammatory cytokines and synergize to induce vascular permeability and KS lesion development
28. Reactivation and persistence of human herpesvirus-8 infection in B cells and monocytes by Th-1 cytokines increased in Kaposi's sarcoma
29. Synergy between basic fibroblast growth factor and human immunodeficiency virus type I Tat protein in induction of Kaposi's sarcoma
30. The histogenesis of Kaposi's sarcoma
31. Macrophages and vascular adhesion molecules in oral Kaposi's sarcoma
32. Factor XIIIa-expressing dermal dendrocytes in AIDS-associated cutaneous Kaposi's sarcomas
33. Human immunodeficiency virus-associated oral Kaposi's sarcoma. A heterogeneous cell population dominated by spindle-shaped endothelial cells
34. Distribution of immunocompetent cells in oral Kaposi's sarcoma (AIDS)
35. Co-expression of endothelial cell and macrophage antigens in Kaposi's sarcoma cells
36. Kaposi's sarcoma (KS) cells express the macrophage associated antigen mannose receptor and develop in peripheral blood cultures of KS patients
37. AIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6
38. Identification of interleukin-1 and platelet-derived growth factor-β as major mitogens for the spindle cells of Kaposi's sarcoma: A combined in vitro and in vivo analysis
39. Effects of cytokines from activated immune cells on vascular cell growth and HIV-1 gene expression: Implications for AIDS-Kaposi's sarcoma pathogenesis
40. Vascular endothelial growth factor regulates angiogenesis and vascular permeability in Kaposi's sarcoma
41. Inflammatory cytokines induce AIDS-Kaposi's sarcoma-derived spindle cells to produce and release basic fibroblast growth factor and enhance Kaposi's sarcoma-like lesion formation in nude mice
42. Inflammatory cytokines induce endothelial cells to produce and release basic fibroblast growth factor and to promote Kaposi's sarcoma-like lesions in nude mice
43. Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma
44. Kaposi's sarcoma: Further immunohistologie evidence of a vascular endothelial origin
45. Lymphatic endothelium and Kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3
46. Kaposi's sarcoma: Immunohistologic evidence for an endothelial origin
47. CD40 antigen is expressed by endothelial cells and tumor cells in Kaposi's sarcoma
48. Cultured, AIDS-related Kaposi's sarcoma cells express endothelial cell markers and are weakly malignant in vitro
49. Regulation of adhesion molecular expression in Kaposi's sarcoma cells
50. Expression of vascular endothelial growth factor receptor-3 and podoplanin suggests a lymphatic endothelial cell origin of Kaposi's sarcoma tumor cells
51. Vascular origin of Kaposi's sarcoma: Expression of leukocyte endothelial adhesion molecule-1, thrombomodulin, and tissue factor
52. Identification and culture of Kaposi's sarcoma-like spindle cells from the peripheral blood of HIV-1-infected individuals and normal controls
53. Circulating spindle cells: Correlation with human herpesvirus-8 (HHV-8) infection and Kaposi's sarcoma
54. Monocytes in Kaposi's sarcoma lesions are productively infected by human herpesvirus 8
55. Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells
56. Expression of human herpesvirus 8-encoded cyclin D in Kaposi's sarcoma spindle cells
57. Expression of HHV-8 latency-associated T0.7 RNA in spindle cells and endothelial cells of AIDS-associated, classical and African Kaposi's sarcoma
58. Expression of K13/v-FLIP gene of human herpesvirus 8 and apoptosis in Kaposi's sarcoma spindle cells
59. Human herpesvirus-8 (HHV-8) gene expression in Kaposi's sarcoma (KS) primary lesions: An in situ hybridization study
60. Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells
61. Kaposi's sarcoma-associated herpesvirus encodes a functional cyclin
62. Visualization of human herpesvirus type 8 in Kaposi's sarcoma by light and transmission electron microscopy
63. Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV
64. Kaposi's sarcoma and new herpesvirus
65. Latent BK virus infection and Kaposi's sarcoma pathogenesis
66. Expansion of cytotoxic CD8+ CD28T cells in healthy ageing people, including centenarians
67. Quantitative analysis of serum IL-6 and its correlation with increased levels of serum IL2R in HIV-I-induced disease
68. Immunologic studies in Kaposi's sarcoma in Uganda
69. Immunological activation markers in the serum of African and European HIV-seropositive and seronegative individuals
70. A distinctive form of soluble CD8 is secreted by stimulated CD8+ cells in HIV-1-infected and high risk individuals
71. The role of immunosuppression and immune-activation in classic Kaposi's sarcoma
72. Clinical aspects of AIDS-related Kaposi's sarcoma
73. Kaposi's sarcoma in HIV-negative homosexual men
74. Immune response to human herpesvirus-8 (HHV-8): Study of natural killer phenotype and activity in Kaposi's sarcoma patients
75. Expression of the natural killer-related receptor for HLA-C on natural killer and T lymphocytes from Kaposi's sarcoma patients
76. Immunological profile of endemic and epidemic Kaposi's sarcoma patients in Dar-es-salaam, Tanzania
77. Prevalence of human herpesvirus 8 infection before the acquired immunodeficiency disease syndrome-related epidemic of Kaposi's sarcoma in East Africa
78. KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma
79. Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients
80. Prevalence and determinants of anti-lytic and anti-latent antibodies to human herpesvirus-8 among Italian individuals at risk of sexually and parenterally transmitted infections
81. Prevalence and risk factors for human herpesvirus 8 infection in northern Cameroon
82. Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen
83. Human herpesvirus 8 seroprevalence in blood donors and lymphoma patients from different regions of Italy
84. Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma
85. The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): Distribution of infection in KS risk groups and evidence for sexual transmission
86. Sexual transmission and the natural history of human herpesvirus 8 infection
87. Interaction of human immunodeficiency virus type 1 and human herpesvirus type 8 infections on the incidence of Kaposi's sarcoma
88. Kaposi's sarcoma associated herpesvirus infection prior to onset of Kaposi's sarcoma
89. Seroconversion for human herpesvirus 8 during HIV infection is highly predictive of Kaposi's sarcoma
90. Human herpesvirus-8 seropositivity and risk of developing Kaposi's sarcoma and other AIDS-related diseases
91. Detection of Kaposi's sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma
92. Kaposi's arcoma after kidney transplantation. Report of complete remission of cutaneous and visceral involvement
93. Monoclonality or oligoclonality of human herpesvirus 8 terminal repeat sequences in Kaposi's sarcoma and other diseases
94. A histologic and flow cytometric study of Kaposi's sarcoma
95. Spindle cell ploidy and proliferation in endemic and epidemic African Kaposi's sarcoma
96. AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth effects
97. Block of AIDS-Kaposi's sarcoma (KS) cell growth, angiogenesis, and lesion formation in nude mice by antisense oligonucleotide targeting basic fibroblast growth factor. A novel strategy for the therapy of KS
98. Characterization of a human Kaposi's sarcoma cell line that induces angiogenic tumors in animals
99. Isolation and characterization of an immortal neoplastic cell line (KS Y-1) from AIDS-associated Kaposi's sarcoma
100. Ocular examination and diagnosis in patients with the acquired immunodeficiency syndrome
101. Blood-brain barrier abnormalities in the acquired immunodeficiency syndrome: Immunohistochemical localization of serum proteins in postmortem brain
102. The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi's sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence
103. HIV-1 Tat protein exits from cells via leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region
104. The Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients
105. Release, uptake, and effects of extracellular HIV-1 Tat protein on cell growth and viral transactivation
106. Kaposi's sarcoma cells: Long-term culture with growth factor from retrovirus-infected CD4+ T cells
107. Interleukin 1 is an autocrine regulator of human endothelial cell growth
108. Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo
109. Inhibition of endothelial cell proliferation by gamma-interferon
110. Human herpesvirus 8 detection in nasal secretions and saliva
111. Restricted tissue distribution of extralesional Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS patients with Kaposi's sarcoma
112. The Kaposi sarcoma-associated herpesvirus (KSHV) is present as an intact latent genome in KS tissue but replicates in the peripheral blood mononuclear cells of KS patients
113. Human herpesvirus type 8 DNA sequences in cell-free plasma and mononuclear cells of Kaposi's sarcoma patients
114. Detection of human herpesvirus 8 DNA in semen from HIV-infected individuals but not healthy semen donors
115. Frequent detection of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in saliva of human immunodeficiency virus-infected men: Clinical and immunologic correlates
116. Detection of human herpesvirus 8 DNA sequences in tissues and bodily fluids
117. α-Interferon inhibits HHV-8 reactivation in primary effusion lymphoma cells and reduces HHV-8 load in cultured PBMC
118. Serologic and molecular evidence of human herpesvirus 8 activation in renal transplant recipients
119. Relationship of HHV8 replication and Kaposi's sarcoma after solid organ transplantation
120. Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients
121. Association of Kaposi's sarcoma associated herpesvirus (KSHV) DNA in bronchoalveolar lavage fluid of HIV infected individuals with bronchoscopically diagnosed tracheobronchial Kaposi's sarcoma
122. + T cells
123. Identification of human herpesvirus 8-specific cytotoxic T-cell responses
124. Human herpesvirus 8 cellular immune responses in homosexual men
125. Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis
126. Identification and analysis of the K5 gene of Kaposi's sarcoma-associated herpesvirus
127. Downregulation of major histocompatibility complex class I molecules by Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins
128. Inhibition of natural killer cell-mediated cytotoxicity by KSHV K5 protein
129. HHV-8 ORF K3 is encoded by a bicistronic multispliced immediate-early mRNA expressed upon virus reactivation
130. Expression of platelet-derived growth factor and its receptor in AIDS-related Kaposi's sarcoma in vivo suggests paracrine and autocrine mechanisms of tumor maintenance
131. Expression of adhesion molecules, platelet-activating factor, and chemokines by Kaposi's sarcoma cells
132. Immunohistochemical detection of bcl-2 in AIDS-associated and classical Kaposi's sarcoma
133. Treatment of HIV-associated Kaposi's sarcoma with paclitaxel
134. Mechanism of Paclitaxel activity in Kaposi's sarcoma
135. Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53
136. Human Kaposi's sarcoma cell-mediated tumorigenesis in human immunodeficiency type 1 Tat-expressing transgenic mice